(Q40674614)

22 September 2017

Trimethoprim-sulfamethoxazole plus amikacin versus ceftazidime monotherapy as empirical treatment in patients with neutropenia and fever (English)

1 reference

22 September 2017

1 reference

1 reference

3

Ljungman P

1 reference

22 September 2017

Engervall P

1

1 reference

22 September 2017

Günther G

2

1 reference

22 September 2017

Lönnqvist B

4

1 reference

22 September 2017

Hast R

5

1 reference

22 September 2017

Stiernstedt G

6

1 reference

22 September 2017

Kalin M

7

1 reference

22 September 2017

Ringertz S

8

1 reference

22 September 2017

Bjökholm M

9

1 reference

22 September 2017

language of work or name

1 reference

1 January 1996

1 reference

Scandinavian Journal of Infectious Diseases

22 September 2017

1 reference

22 September 2017

28

1 reference

22 September 2017

3

1 reference

22 September 2017

297-303

1 reference

From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever

22 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F00365549609027177

Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549609027177

Management of fever in patients with cancer and treatment-induced neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549609027177

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549609027177

Ceftazidime Monotherapy for Empiric Treatment of Febrile Neutropenic Patients: A Metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549609027177

Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549609027177

Septicemia in patients with hematological disorders and neutropenia. A retrospective study of causative agents and their resistance profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549609027177

Ceftazidime as initial therapy in febrile patients with acute leukemia during induction chemotherapy. Leukemia Group of Middle Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549609027177

Monitoring of hearing during treatment of leukaemia with special reference to the use of amikacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549609027177

The role of Gram-positive therapy in the neutropenic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549609027177

Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549609027177

Trimethoprim and Sulphamethoxazole Inhibition of Haematopoiesis in Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549609027177

Ceftazidime monotherapy is as effective as ceftazidime combined with gentamicin in the treatment of febrile neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549609027177

Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549609027177

Emergence of vancomycin resistance in coagulase-negative staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549609027177

10.3109/00365549609027177

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference